SEC Form 4 · accession 0001061983-26-000072
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sung Lee
Officer — EVP, Chief Financial Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 2, 2026 · 5:17 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2026 | M | 1,112 | $48.51 | A | 64,333 | D | |
| Common Stock | Jul 1, 2026 | S | 1,112 | $87.79 | D | 63,221 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) | $48.51 | Jul 1, 2026 | M | 1,112 | D | Jun 2, 2025 | May 30, 2034 | Common Stock | 1,112 | 26,709 | D |